mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.005 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.006 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |
mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.02 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.02 |